Death Domain Mutagenesis of KILLER/DR5 Reveals Residues Critical for Apoptotic Signaling
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (18), 14939-14945
- https://doi.org/10.1074/jbc.m100399200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Caspases – controlling intracellular signals by protease zymogen activationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tractOncogene, 1999
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- Apoptosis by Death FactorCell, 1997
- Programmed Cell Death in Animal DevelopmentCell, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992